The specific depot agent (GM-CSF vs FLT3L) utilized to concentrate host myeloid cells informed the composition of myeloid cells at the depot and tumor sites and influenced the long-term phenotypic profiles of both the adoptively transferred and host T cells. The gene discussed is FLT3LG; the disease is neoplasm.